Crisis Point: Insulin Access in the United States
Welcome back to Crisis Point. A special episode focuses on the issue of insulin accessibility and affordability in the United States, with four experts in the diabetes arena weighing in on the topic.
Bincy Abraham, MD: Treating IBD Patients With Upadacitinib
A greater proportion of the upadacitinib 15 mg and upadacitinib 30 mg group achieved clinical remission based on the Crohn’s Disease Activity Index
Evan Dellon, MD, MPH: New Late-Breaking Data on Dupilumab for EoE
Dupilumab represents the first ever approved treatment for EoE.
Paul Feuerstadt, MD: Exciting New Data on RBX2660
If approved by the FDA, RBX2660 would be the first approved live microbiota therapeutic for the treatment of recurrent CDI.
Aasma Shaukat, MD, MPH: The Current State of Colorectal Cancer Screenings
The COVID-19 pandemic has hurt the effort of colorectal cancer screenings.
How Do We Treat Children with Systemic Eczema Therapies?
With dupilumab already available and JAK inhibitors on the way, clinicians have a bevy of treatments designated for pediatric patients.
The Future of Tailored Alopecia Treatment
In consideration of emerging JAK inhibitor options, and the current prescribing availability of baricitinib.
Advances to Alopecia Areata Treatment and Diagnostics
Brett King, MD, PhD, explains the altered screening and care strategies for patients following baricitinib's approval.
Baricitinib Has Reinvigorated Patients with Alopecia Areata
Brett King, MD, PhD, discusses the newly available JAK inhibitor—the first systemic therapy approved for the hair-loss condition.
Why Ruxolitinib May Alter Atopic Dermatitis Care Options
The JAK inhibitor received FDA approval for vitiligo this summer. Investigator now see it as a potent non-steroidal option for eczema.
How Likely Is A Vaccine for Acne?
Christopher Bunick, MD, discusses the future progress of acne management—including a potential mRNA vaccine current in development.
What Does an Acne Patient Want From Clinical Care?
With a broadening array of drug options, involving patients in the care process may be a key to adherence and long-term success.
How Narrow-Spectrum Antibiotics Shifted Acne Treatment Strategy
Christopher Bunick, MD, PhD, reviews the benefit of antibiotic resistance, blood-brain barrier penetration, and digestive distress with agents like sarecycline.
What Does It Take to Initiate JAK Inhibitors for Psoriasis?
Peter Lio, MD, shares his strategy for advancing severely impacted patients from systemic therapy to either upadacitinib or abrocitinib.
Heart Team: Making Ground on Women's Cardiovascular Health
Martha Gulati, MD, joins episode 2 to discuss the burden of gender disparity in cardiovascular research, screening and care.
Dr. Reid Robison, MD: Treatment-Resistant Depression and Psychedelic Medicine Acceptance
Dr. Reid Robison, MD, MBA, described his research on clinical depression and the recent acceptance of psychedelic medicine.
Discussion On Older Homeless Mortality Rates, Future Research
Rebecca T. Brown, MD, MPH, describes contributing factors to older homeless adult mortality and future topics of interest in this field.
Heart Team: The Evolving Role of Kidney Disease in CVD
In the first episode of our monthly series, cardiologists Jorge Plutzky, MD, and Michael Farkouh, MD, interview nephrologist Matthew Weir, MD.
Addressing Older Homeless Adult Health Concerns
Rebecca T. Brown, MD, MPH, discusses the growing prevalence of older homeless adults, and what diseases community leaders and caregivers are combating most frequently in them.
Sanjai Rao, MD: Long-Acting Injectables for Schizophrenia
Treatment adherence remains a concern in psychiatry.
Anita Clayton, MD: Women's Issues in Psychiatry
Postpartum depression rates have increased since the COVID-19 pandemic.
Michael Thase, MD: Risk Factors for Chronically Depressed Patients
Alcohol, stress, drug use, and not seeking help are all risk factors for chronic depression.
John J. Miller, MD: Guidance on Cannabis Use in Psychiatry
CBD has shown promise in treating anxiety and psychosis.
Christopher Schneck, MD: Early Interventions for Bipolar Disorder
There remains a need for better treatments for bipolar disorder when it is identified early.
Joseph Goldberg, MD: Treating Mixed Feature Depression
Mixed feature depression can be difficult to diagnose because the symptoms can be similar to other psychiatric disorders.
M. Katherine Shear, MD: Addressing Grief After a Loss
There remains a need for more research into the connection between grief and depression following a death.
Rethinking Psychiatry With Dr. Steve Levine: Episode 4
Dr. Levine talks with Dr. Lisa Harding about how clinicians can best improve patient care in psychiatry.
David Hudesman, MD: Where Drug Development is Going in IBD
Dr. David Hudesman expects drug developers to continue to target biologics for the treatment of IBD.
Jennifer Green, MD: Initiating, Accessing and Adjusting Insulin for Type 2 Diabetes
The Duke expert reviews key strategies for starting and continuing care with the pivotal glycemic control agent.
Arun Sanyal, MD: ALT Fluctuations in NAFLD
ALT fluctuations remained stable for patients with NAFLD throughout disease progression.